Testing AI That Reads MRI Scans to Help Diagnose Gliomas
Original title: AI-driven Processing and Analysis of Glioma Imaging Data
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
No phase is listed, so this is still research being worked out, not care your own doctor can give you.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study is testing whether AI can read brain MRI scans well enough to help doctors spot and understand a glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary without a biopsy.
Who this trial is for. This study is for adults aged 18 to 60 who were diagnosed with a glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary between 2019 and 2024 and had surgery to remove the tumor, with or without chemotherapy or radiation. It uses their existing MRI scans and clinical records to build and test AI tools that try to find tumors earlier, outline them on scans, and predict the tumor type and how aggressive it is.
Where it stands. This study has not reported results. Researchers are still collecting scans and records and building the AI models. They want to see how accurately the AI can spot a tumor, outline it, and describe it from the scan alone, and how well it can predict changes in the tumor over time. Those answers are not in yet.
What this means, and what it doesn't
What it could mean: If it works, this kind of AI could one day help doctors read scans faster and lean less on biopsies. Nothing here changes care today. The study uses scans and records that already exist, so someone who fits the description could ask their care team whether their information is part of work like this, or whether a study like this is running near them.
What it doesn't mean: This does not mean the AI is ready or proven. A trial is a test, not a treatment you can count on. Being part of one is not a guarantee that it will help you. It is not a promise of a cure. Nobody should change their treatment plan based on this.
Source: ClinicalTrials.gov, July 14, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.